CFI-402257 是 Mps1/TTK 激酶的选择性抑制剂（Mps1 Ki = 0.09 nM；EC50 = 6.5 nM），可用于肝细胞癌疾病的研究。

CFI-402257 is a selective inhibitor of Mps1/TTK kinase (Mps1 Ki = 0.09 nM; EC50 = 6.5 nM)and can be used in studies about hepatocellular carcinoma diseases.

1610759-22-2

C28H30N6O3

498.58

DMSO:112.5mg/mL (225.6mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years